6/1/2022 Frailty in patients with newly diagnosed diffuse large B-cell lymphoma receiving curative-intent therapy: a population-based study Vijenthira A, Mozessohn L, Nagamuthu C, Liu N, Blunt D, Alibhai S, Prica A, Cheung MC. J Natl Compr Canc Netw. 2022; 20(6):635-42. Epub 2022 Jun 1. DOI: https://doi.org/10.6004/jnccn.2022.7014
2/22/2022 The impact of oral hypoglycemics and statins on outcomes in myelodysplastic syndromes Brailovski E, Li Q, Liu N, Leber B, Khalaf D, Sabloff M, Christou G, Yee K, Chodirker L, Parmentier A, Siddiqui M, Mamedov A, Zhang L, Liu Y, Earle CC, Cheung MC, Mittmann N, Buckstein RJ, Mozessohn L. Ann Hematol. 2022; 101(5):1023-30. Epub 2022 Feb 22. DOI: https://doi.org/10.1007/s00277-022-04802-1
9/21/2020 Real-world costs of azacitidine treatment in patients with higher-risk myelodysplastic syndromes/low blast-count acute myeloid leukemia Mozessohn L, Cheung MC, Mittmann N, Earle CC, Liu N, Buckstein R. JCO Oncol Pract. 2021; 17(4):e517-25. Epub 2020 Sep 21. DOI: https://doi.org/10.1200/op.20.00446